Innovotech Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
888.80
902.60
707.80
1,005.60
990.30
826.90
Cost of Goods Sold (COGS) incl. D&A
436.80
365.00
296.50
283.00
293.40
223.10
Gross Income
452.10
537.60
411.30
722.60
696.90
603.80
SG&A Expense
1,587.80
896.30
657.10
636.50
672.60
783.70
EBIT
1,135.70
358.80
245.80
86.10
24.30
179.90
Unusual Expense
-
-
-
246.40
745.20
49.60
Non Operating Income/Expense
280.10
197.10
73.90
-
-
-
Interest Expense
60.60
69.10
78.60
69.60
27.90
0.70
Pretax Income
915.90
230.70
250.60
229.80
741.70
130.90
Income Tax
88.60
21.00
-
14.30
11.70
3.30
Consolidated Net Income
827.30
209.60
250.60
215.50
753.40
127.60
Net Income
827.30
209.60
250.60
215.50
753.40
127.60
Net Income After Extraordinaries
827.30
209.60
250.60
215.50
753.40
127.60
Net Income Available to Common
827.30
209.60
250.60
215.50
753.40
127.60
EPS (Basic)
0.03
0.01
0.01
0.01
0.02
-
Basic Shares Outstanding
28,608.60
28,739.60
28,739.60
28,739.60
32,082.10
35,623.20
EPS (Diluted)
0.03
0.01
0.01
0.01
0.02
-
Diluted Shares Outstanding
28,608.60
28,739.60
28,739.60
28,739.60
32,082.10
35,623.20
EBITDA
1,080.50
308.90
203.10
105.50
41.10
164.50
Non-Operating Interest Income
0.30
0.00
-
0.10
0.00
-

About Innovotech

View Profile
Address
2011-94th Street
Edmonton Alberta T6N 1H1
Canada
Employees -
Website http://www.innovotech.ca
Updated 07/08/2019
Innovotech, Inc. engages in the development and provision of solutions for medical, agricultural and industrial problems caused by microbial biofilms. Its products include the MBEC Assay, InnovoSIL, various coatings of MBEC Lids, and Agress & AgreGuard. The company was founded by Merle Olson and Howard Ceri on January 31, 2001 and is headquartered in Edmonton, CA.